February 14, 2018 / 8:52 PM / in 4 days

BRIEF-FDA Approves Janssen Pharmaceutical's Erleada For A Certain Type Of Prostate Cancer

Feb 14 (Reuters) - The U.S. Food and Drug Administration:

* SAYS APPROVED JANSSEN PHARMACEUTICAL‘S ERLEADA FOR A CERTAIN TYPE OF PROSTATE CANCER USING NOVEL CLINICAL TRIAL ENDPOINT‍​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below